ReviewOne health (Amsterdam, Netherlands)2025
Microbial biopesticides: A one health perspective on benefits and risks.
Review in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Review
- Rethinking microbial biopesticide development and uptake.World journal of microbiology & biotechnology · 2026Review
- Climate and socioeconomic factors drive heterogeneous dengue risk escalation in the Chinese population.Communications medicine · 2026Article
- Microorganism-Based Biological Products for Agriculture: From Strain Selection to Production Organization.Microorganisms · 2026Review
- Review
- ExploringMicrobiology (Reading, England) · 2026Review
- Microbial Biotechnology in Agriculture.Progress in molecular and subcellular biology · 2026Review
- Developments and food safety considerations concerning genetically engineered microbial crop protection agents and biostimulants.Journal of pesticide science · 2025Article
- Benefits and challenges of upcoming microbial plant protection applications sustaining planetary health.iScience · 2025Review
- Use ofBiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Controlling insect pests that destroy crop and spread diseases will become increasingly crucial for addressing the food demands of a growing global population and the expansion of vector-borne diseases. A key challenge is the development of a balanced approach for sustainable food production and disease control in 2050 and beyond. Microbial biopesticides, derived from bacteria, viruses, fungi, protozoa, or nematodes, offer potentially significant benefits for promoting One Health and contributing to several United Nations Sustainable Development Goals (SDGs). This narrative review examines the benefits and risks of microbial biopesticides from a One Health perspective, focusing on the Americas and Europe, and aligned with respective SDGs. The value of biopesticides in sustainable agriculture and integrated pest management (IPM) approaches for food security, particularly SDG 2 (Zero Hunger) and SDG 1 (No Poverty) has been widely recognized, with relatively fewer adverse effects to people and the environment than synthetic pesticides. With increased demand and usage, microbial biopesticides can be expected to contribute further to additional SDGs such as SDG 12 (responsible consumption and production) through waste recycling for biopesticide production and remediation of polluted ecosystems, and by reducing vector-borne disease burdens such as malaria and dengue. Nevertheless, the prudent and judicious application of microbial biopesticides is crucial to ensuring their effectiveness and maximizing their One Health benefits while minimizing pest resistance and unintended impacts. From a One Health perspective, this goal involves incorporating microbial biopesticides into a comprehensive biological control strategy within an IPM framework for sustainable agriculture and for controlling vector-borne diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.